Accel [ACCEL] vs Protean eGov [PROTEAN] Detailed Stock Comparison
Accel
BSE
Loading...
Protean eGov
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Accel wins in 6 metrics, Protean eGov wins in 11 metrics, with 0 ties. Protean eGov appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Accel | Protean eGov | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 41.38 | 37.59 | Protean eGov |
| Price-to-Book Ratio | 1.55 | 3.55 | Accel |
| Debt-to-Equity Ratio | 99.83 | 6.86 | Protean eGov |
| PEG Ratio | N/A | 2.92 | N/A |
| EV/EBITDA | 10.52 | 32.89 | Accel |
| Profit Margin (TTM) | 1.38% | 11.14% | Protean eGov |
| Operating Margin (TTM) | 3.82% | 5.28% | Protean eGov |
| EBITDA Margin (TTM) | 3.82% | 5.28% | Protean eGov |
| Return on Equity | 3.16% | 9.26% | Protean eGov |
| Return on Assets (TTM) | 1.11% | 7.08% | Protean eGov |
| Free Cash Flow (TTM) | $83.16M | $1.45B | Protean eGov |
| Dividend Yield | 1.80% | N/A | N/A |
| 1-Year Return | -29.83% | -41.31% | Accel |
| Price-to-Sales Ratio (TTM) | 0.54 | 4.16 | Accel |
| Enterprise Value | $1.49B | $28.39B | Protean eGov |
| EV/Revenue Ratio | 0.92 | 3.32 | Accel |
| Gross Profit Margin (TTM) | 35.14% | 18.14% | Accel |
| Revenue per Share (TTM) | $26 | $211 | Protean eGov |
| Earnings per Share (Diluted) | $0.37 | $23.31 | Protean eGov |
| Beta (Stock Volatility) | 0.22 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Accel vs Protean eGov Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Accel | 5.46% | 4.91% | -2.05% | -2.81% | -15.20% | -27.48% |
| Protean eGov | 0.49% | 15.18% | 8.57% | -19.92% | -40.24% | -42.30% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Accel | -29.83% | -8.82% | 33.91% | 71.75% | 85.06% | 85.06% |
| Protean eGov | -41.31% | -41.31% | -41.31% | -41.31% | -41.31% | -41.31% |
Performance & Financial Health Analysis: Accel vs Protean eGov
| Metric | ACCEL | PROTEAN |
|---|---|---|
| Market Information | ||
| Market Cap | ₹881.43M | ₹35.53B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 6,840 | 1,036,841 |
| 90 Day Avg. Volume | 11,810 | 655,775 |
| Last Close | ₹16.23 | ₹851.10 |
| 52 Week Range | ₹13.56 - ₹31.69 | ₹716.05 - ₹1,535.00 |
| % from 52W High | -48.79% | -44.55% |
| All-Time High | ₹39.80 (Jan 10, 2022) | ₹1,535.00 (Feb 03, 2025) |
| % from All-Time High | -59.22% | -44.55% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.07% |
| Quarterly Earnings Growth | 0.20% | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.11% |
| Operating Margin (TTM) | 0.04% | 0.05% |
| Return on Equity (TTM) | 0.03% | 0.09% |
| Debt to Equity (MRQ) | 99.83 | 6.86 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹9.91 | ₹246.76 |
| Cash per Share (MRQ) | ₹0.29 | ₹73.91 |
| Operating Cash Flow (TTM) | ₹135.50M | ₹2.09B |
| Levered Free Cash Flow (TTM) | ₹20.38M | ₹924.60M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.80% | N/A |
| Last 12-Month Dividend | ₹0.30 | N/A |
Valuation & Enterprise Metrics Analysis: Accel vs Protean eGov
| Metric | ACCEL | PROTEAN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 41.38 | 37.59 |
| Forward P/E | N/A | 25.06 |
| PEG Ratio | N/A | 2.92 |
| Price to Sales (TTM) | 0.54 | 4.16 |
| Price to Book (MRQ) | 1.55 | 3.55 |
| Market Capitalization | ||
| Market Capitalization | ₹881.43M | ₹35.53B |
| Enterprise Value | ₹1.49B | ₹28.39B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.92 | 3.32 |
| Enterprise to EBITDA | 10.52 | 32.89 |
| Risk & Other Metrics | ||
| Beta | 0.22 | N/A |
| Book Value per Share (MRQ) | ₹9.91 | ₹246.76 |
Financial Statements Comparison: Accel vs Protean eGov
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ACCEL | PROTEAN |
|---|---|---|
| Revenue/Sales | ₹461.18M | ₹2.22B |
| Cost of Goods Sold | ₹299.12M | ₹1.68B |
| Gross Profit | ₹162.06M | ₹540.40M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹18.70M | ₹38.90M |
| EBITDA | ₹54.73M | ₹344.30M |
| Pre-Tax Income | ₹16.34M | ₹252.40M |
| Income Tax | ₹17.05M | ₹48.40M |
| Net Income (Profit) | ₹-711,000 | ₹204.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ACCEL | PROTEAN |
|---|---|---|
| Cash & Equivalents | ₹14.64M | ₹378.50M |
| Total Current Assets | ₹605.48M | ₹4.71B |
| Total Current Liabilities | ₹679.90M | ₹2.26B |
| Long-Term Debt | ₹429.59M | ₹602.00M |
| Total Shareholders Equity | ₹645.72M | ₹9.99B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹378.00M | ₹1.15B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ACCEL | PROTEAN |
|---|---|---|
| Operating Cash Flow | N/A | ₹86.21M |
| Capital Expenditures | N/A | ₹-33.89M |
| Free Cash Flow | N/A | ₹-12.03M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ACCEL | PROTEAN |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 6,840 | 1,036,841 |
| Average Daily Volume (90 Day) | 11,810 | 655,775 |
| Shares Outstanding | 57.57M | 40.55M |
| Float Shares | 13.59M | 30.87M |
| % Held by Insiders | 0.71% | 0.20% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Accel vs Protean eGov
| Metric | ACCEL | PROTEAN |
|---|---|---|
| Last 12-Month Dividend | ₹0.30 | N/A |
| Last 12-Month Dividend Yield | 1.80% | N/A |
| 3-Year Avg Annual Dividend | ₹0.30 | N/A |
| 3-Year Avg Dividend Yield | 1.39% | N/A |
| 3-Year Total Dividends | ₹0.90 | N/A |
| Ex-Dividend Date | Sep 13, 2024 | N/A |